MUSTANG BIO, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
MUSTANG BIO, INC. (MBIO) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-19
- MUSTANG BIO, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -1.00%.
- MUSTANG BIO, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 0.00%.
- MUSTANG BIO, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -1.00%.
- MUSTANG BIO, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -1.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 10 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|---|
| 2024-12-31 | -1.00% 10-K · filed 2026-03-19 | |
| 2023-12-31 | 0.00% 10-K · filed 2025-03-28 | |
| 2022-12-31 | -1.00% 10-K · filed 2024-03-11 | |
| 2021-12-31 | -1.00% 10-K · filed 2023-03-30 | |
| 2020-12-31 | -1.00% 10-K · filed 2022-03-23 | |
| 2019-12-31 | 0.00% 10-K · filed 2021-03-24 | |
| 2018-12-31 | 0.00% 10-K · filed 2020-03-16 | |
| 2017-12-31 | -2.00% 10-K · filed 2019-03-18 | |
| 2016-12-31 | -3.00% 10-K · filed 2018-03-29 | |
| 2015-12-31 | -2.00% 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |